USANA Health Sciences
Salt Lake City, Utah, United States · Dietary Supplements, Fitness, Health Care
USANA Health Sciences, Inc. is a global health and wellness company, focusing on the research, development, and marketing of personal care, nutritional supplements, and weight-management products. It operates as a direct selling company, offering its products through independent distributors in approximately 24 markets worldwide.
Key facts
- Headquarters
- Salt Lake City, Utah, United States
- Employees
- 1,900
- Industries
- Dietary Supplements, Fitness, Health Care
- Status
- Public (USNA)
- Website
- www.usana.com
- Company page
Recent activity at USANA Health Sciences
- : SEC 8-K (1.01): On September 30, 2026, USANA Health Sciences, Inc. entered into a First Amendment to its Third Amended and Restated Credit Agreement, which involves changes to the minimum Consolidated EBITDA covenant and limits on property dispositions. The Amendment increases the required Consolidated EBITDA to $100 million starting from the fiscal quarter ending October 3, 2026, with a reduced requirement if certain conditions are met. Additionally, it allows for a significant increase in the value of assets that can be disposed of annually and grants USANA Australia Pty, Ltd permission to sell real property in Sydney, Australia. The Credit Agreement, initially dated June 27, 2025, remains effective with these modifications and has a revolving credit facility totaling $75 million, expiring June 27, 2030.
- : SEC 8-K (7.01):
- : USANA Health Sciences renews partnership with Nordiq Canada for 2030 Winter Olympics.
- : SEC 8-K (7.01):
- : SEC 8-K (7.01): USANA Health Sciences, Inc. has issued a Regulation FD disclosure as part of its SEC Form 8-K filing on February 17, 2026. The filing includes a press release and management commentary, both dated February 17, 2026, that provide critical updates on the company’s financial performance and strategic initiatives. This disclosure is significant for shareholders and analysts as it may contain insights regarding the company's operations and future direction. The timing indicates an effort to keep investors informed in compliance with disclosure regulations.
- : SEC 8-K (2.02): On February 17, 2026, USANA Health Sciences, Inc. announced its financial results for the fourth quarter and the fiscal year ended January 3, 2026. The filing indicates that the company will also provide a 'Management Commentary' document on its website, and a conference call with executives will take place for investors, which will include initial remarks followed by a Q&A session. This disclosure reflects the company's financial performance and strategies moving forward and highlights the key financial metrics for the reporting period.
- : SEC 8-K (7.01): On January 12, 2026, USANA Health Sciences, Inc. announced preliminary net sales figures for the fiscal year that ended on January 3, 2026. The company provided initial net sales guidance for fiscal year 2026 in the press release issued. The announcement serves to inform investors and stakeholders of the company's performance and forecast, which are essential for financial planning and analysis. A copy of the press release is attached as Exhibit 99.1, indicating the company’s efforts to maintain transparency with its financial disclosures.
- : USANA Health Sciences Appoints Kevin Guest as Chief Executive Officer
- : SEC 8-K (5.02): On January 8, 2026, USANA Health Sciences, Inc. announced a leadership transition wherein Jim Brown stepped down as Chief Executive Officer and President. He will retain an advisory role as determined by the Board of Directors. Kevin Guest, who is currently the Executive Chairman of the Board and has previously served as Chief Executive Officer, will take over the CEO position again while also continuing as Chairman of the Board. This leadership change appears to be a strategic decision to ensure stable leadership during a critical period for the company.
- : SEC 8-K (5.02): On January 8, 2026, USANA Health Sciences, Inc. announced that Jim Brown has stepped down as Chief Executive Officer and President, transitioning to an advisory role. Kevin Guest, who has served as Executive Chairman, will reassume the role of Chief Executive Officer while continuing as Chairman of the Board. There are currently no arrangements disclosed regarding Mr. Brown's or Mr. Guest's compensation related to their transitions. The Compensation Committee will finalize and disclose these arrangements shortly, indicating ongoing changes within USANA’s leadership structure.
Leadership
- Kevin Guest, Chief Executive Officer
- Kathryn Armstrong, Chief Scientific Officer
- Paul Jones, Chief People Officer
- Walter Noot, Chief Operating Officer
Verified email and direct lines for USANA Health Sciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
USANA Health Sciences files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
USANA Health Sciences in the news
- USANA Health Sciences and University of Utah Athletics Announce New Partnership - PR Newswire (Oct 07, 2026)
- USANA Health Sciences Reports Second Quarter 2026 Results - Business Wire (Aug 04, 2026)
- USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance (Aug 04, 2026)
- USANA Schedules Second Quarter 2026 Earnings Release and Conference Call - Business Wire (Jul 14, 2026)
- USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade) (NYSE:USNA) - Seeking Alpha (Aug 05, 2026)
- USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition - PR Newswire (Jul 20, 2026)
- Why is USANA Health Sciences stock collapsing today? - Investing.com (Aug 05, 2026)
- USANA Health Sciences Reports First Quarter 2026 Results - Business Wire (May 05, 2026)
Companies similar to USANA Health Sciences
- Cult.fit · Dietary Supplements, Fitness, Health Care, Nutrition, Wellness
- Pure Barre · Dietary Supplements, Fitness, Health Care, Nutrition, Wellness
- Thorne · Dietary Supplements, Fitness, Health Care, Nutrition, Wellness
- Hyland’s Consumer Health · Dietary Supplements, Fitness, Health Care, Nutrition, Wellness
- LifeVantage · Dietary Supplements, Fitness, Health Care, Nutrition, Wellness
About USANA Health Sciences: questions and answers
What does USANA Health Sciences do?
USANA Health Sciences, Inc. is a global health and wellness company, focusing on the research, development, and marketing of personal care, nutritional supplements, and weight-management products. It operates as a direct selling company, offering its products through independent distributors in approximately 24 markets worldwide.
Where is USANA Health Sciences headquartered?
USANA Health Sciences is headquartered in Salt Lake City, Utah, United States.
How many employees does USANA Health Sciences have?
USANA Health Sciences has about 1,900 employees.
Who leads USANA Health Sciences?
Kevin Guest is a Chief Executive Officer at USANA Health Sciences.
What is the latest news on USANA Health Sciences?
On Oct 05, 2026, SEC 8-K (1.01): On September 30, 2026, USANA Health Sciences, Inc. entered into a First Amendment to its Third Amended and Restated Credit Agreement, which involves changes to the minimum Consolidated EBITDA covenant and limits on property dispositions. The Amendment increases the required Consolida
Is USANA Health Sciences a public company?
Yes. USANA Health Sciences is publicly traded under the ticker USNA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy